LRRK2 and Parkinson disease: Furthermore, LRRK2 expression is increased in non-classical monocytes in iPD patients relative to healthy controls (HCs) (Cook et al., 2017), suggesting LRRK2 dysfunction in immune cells may be a useful biomarker in PD and may be important for its pathophysiology.